Event: DIA Japan Annual Meeting 2025
Date: Oct 19-21,2025
Location: 3-11-1 Ariake, Koto-ku, Tokyo, 135-0063 Japan
The 22nd DIA Japan Annual Meeting will take place in Tokyo on October 19–21, 2025, under the theme “Strong Ties of Japan with Asia and the World for Delivering ‘Tomorrow’s Normal’ to Patients.” With rapid globalization of healthcare and advances in AI and digital technologies, drug development and pharmacovigilance are evolving quickly. Asia plays an increasingly vital role in global healthcare, making collaboration between Japan, Asia, and the world essential for driving innovation and bringing new therapies to patients.
This year’s meeting will unite local and global stakeholders to strengthen partnerships, share insights, and shape a healthier “Tomorrow’s Normal.” An English-language track has been added to encourage global dialogue, foster exchange on the latest developments, and enhance international cooperation. Participants are invited to actively engage and contribute to the future of medical innovation.
AlphaLife Sciences is excited to participate and share our insights at the event. We look forward to engaging with you in person!
Booth Number: 38
Presentation from AlphaLife Sciences:
Date: Oct 20
Time:12:55～13:45 JST
Room:Track 4 (609)
Speaker: Sharon Chen, Founder and CEO, AlphaLife Sciences
Topic: How Leading Global Pharma Embraces AI to Automate Regulatory and Medical Documents with Quality Control
In an era where regulatory requirements demand precision, speed, and transparency, pharmaceutical organizations are increasingly leveraging artificial intelligence to transform medical and regulatory document development. This session will highlight how next-generation AI solutions are being applied to produce critical documents—including study protocols, clinical study reports, and investigator brochures—while maintaining rigorous standards of quality, auditability, and compliance.
Drawing on real-world implementations, we will explore practical approaches to integrating AI within existing governance frameworks and aligning with global health authority expectations. Participants will gain insights into how industry leaders are shortening development cycles, enhancing document reliability, and fostering smoother collaboration across functions.
Join us to discover how AuroraPrime is advancing the future of regulatory and scientific writing, setting new standards for efficiency, compliance, and innovation across the pharmaceutical landscape.
To request a meeting, fill out the form provided and a representative will be in contact soon to schedule.